Compare
Lakeland Industries Inc vs Establishment Labs Holdings Inc. vs Inogen Inc vs Sanara MedTech Inc.
| Latest fiscal year | Lakeland Industries Inc LAKE | Establishment Labs Holdings Inc. ESTA | Inogen Inc INGN | Sanara MedTech Inc. SMTI |
|---|---|---|---|---|
| Year ended | 2026-01-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $192.65M | $211.08M | $348.67M | $103.12M |
| Revenue growth (YoY) | +15.2% | +27.1% | +3.9% | +19.0% |
| Gross margin | 32.9% | 69.3% | 44.2% | 92.7% |
| Operating margin | -8.1% | -18.5% | -8.7% | 7.1% |
| Net margin | -13.1% | -24.2% | -6.5% | -36.4% |
| Net income | -$25.31M | -$51.06M | -$22.75M | -$37.56M |
| EPS (Diluted) | -$2.63 | -$1.72 | -$0.86 | -$4.36 |
| Operating cash flow | -$15.75M | -$50.89M | -$11.22M | $6.79M |
| Free cash flow | -$16.42M | -$56.94M | -$13.74M | $2.16M |
| Cash & equivalents | n/a | $75.57M | $103.73M | $16.58M |
| Total assets | $209.93M | $357.17M | $298.62M | $72.94M |
| Total liabilities | $80.81M | $333.62M | $106.39M | $67.01M |
| Shareholders' equity | $129.13M | $23.55M | $192.23M | $5.94M |
| Return on year-end equity | -19.6% | -216.9% | -11.8% | -632.5% |
| Shares outstanding | 9.81M | 29.30M | 27.23M | 8.95M |
Revenue, most recent five fiscal years
| Fiscal year | Lakeland Industries Inc | Establishment Labs Holdings Inc. | Inogen Inc | Sanara MedTech Inc. |
|---|---|---|---|---|
| Latest | $192.65M Ended 2026-01-31 | $211.08M Ended 2025-12-31 | $348.67M Ended 2025-12-31 | $103.12M Ended 2025-12-31 |
| 1 year earlier | $167.21M Ended 2025-01-31 | $166.03M Ended 2024-12-31 | $335.70M Ended 2024-12-31 | $86.67M Ended 2024-12-31 |
| 2 years earlier | $124.69M Ended 2024-01-31 | $165.15M Ended 2023-12-31 | $315.66M Ended 2023-12-31 | $64.99M Ended 2023-12-31 |
| 3 years earlier | $112.85M Ended 2023-01-31 | $161.70M Ended 2022-12-31 | $377.24M Ended 2022-12-31 | $45.84M Ended 2022-12-31 |
| 4 years earlier | $118.39M Ended 2022-01-31 | $126.68M Ended 2021-12-31 | $358.00M Ended 2021-12-31 | $24.14M Ended 2021-12-31 |